Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.53 |
| ▸ | KLK7 | P49862 | 1/20 | 0.51 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.51 |
| ▸ | CTSS | P25774 | 4/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | SYK | P43405 | 1/20 | 0.50 |
| ▸ | CTSK | P43235 | 4/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.49 |
| ▸ | REN | P00797 | 2/20 | 0.48 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.46 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14997847 | 1.00 | PPARA (0.53) | PPARAKLK7KLK5CTSSPPARG | |
| SCHEMBL10887447 | 1.00 | PPARA (0.53) | PPARAKLK7KLK5CTSSPPARG | |
| Hydrochloric Acid SCHEMBL11597785 | 0.99 | PPARA (0.52) | PPARAKLK7KLK5CTSSPPARG | |
| SCHEMBL11599295 | 0.93 | CTSL (0.60) | CTSSCTSKACERENCTSL | |
| SCHEMBL11598828 | 0.93 | REN (0.53) | PPARAKLK7KLK5CTSSCTSK | |
| SCHEMBL11597960 | 0.92 | REN (0.50) | PPARAKLK7KLK5CTSSPPARG | |
| SCHEMBL8984141 | 0.92 | PPARA (0.54) | PPARAKLK7KLK5CTSSPPARG | |
| SCHEMBL25384406 | 0.92 | REN (0.49) | PPARAKLK7KLK5CTSSSYK | |
| SCHEMBL21778857 | 0.92 | REN (0.49) | PPARAKLK7KLK5CTSSSYK | |
| SCHEMBL11647966 | 0.92 | REN (0.49) | PPARAKLK7KLK5CTSSSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250170237-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | UNIVERSITEIT GENT (BE) | 2025-05-29 | — | — | US | disclosed |
| EP-4482849-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | Council of Scientific & Industrial Research (IN) | 2025-01-01 | — | — | EP | disclosed |
| US-12134664-B2 | Muramyl peptide derivatives | BHARAT BIOTECH INTERNATIONAL LTD. (IN) | 2024-11-05 | — | — | US | disclosed |
| WO-2023161962-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-08-31 | — | — | WO | disclosed |
| EP-3389643-B1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INT LTD (IN) | 2023-05-03 | — | — | EP | disclosed |
| EP-3389643-B1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INT LTD (IN) | 2023-05-03 | — | — | EP | disclosed |
| CN-108884132-B | Muramyl peptide derivatives a compound their synthesis and their use | 巴拉特生物技术国际有限公司 | 2022-10-04 | — | — | CN | disclosed |
| EP-3387005-B1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INT LTD (IN) | 2022-08-24 | — | — | EP | disclosed |
| US-9085605-B2 | Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) | 2015-07-21 | — | — | US | disclosed |
| US-20130143826-A1 | CHEMICAL SYNTHESIS AND ANTI-TUMOR AND ANTI-METASTATIC EFFECTS OF DUAL FUNCTIONAL CONJUGATE | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) | 2013-06-06 | — | — | US | disclosed |
| US-20130143826-A1 | CHEMICAL SYNTHESIS AND ANTI-TUMOR AND ANTI-METASTATIC EFFECTS OF DUAL FUNCTIONAL CONJUGATE | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) | 2013-06-06 | — | — | US | disclosed |
| US-4082736-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
| US-4082735-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12134664-B2 | Muramyl peptide derivatives | NOD2, NGLY1, LNPEP | PPARA 1402/4885KLK7 2576/4885KLK5 3233/4885 |
| US-20250170237-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | NOD2, NOD1, TLR9 | PPARA 1827/4885KLK7 3524/4885KLK5 3787/4885 |
| US-20130143826-A1 | CHEMICAL SYNTHESIS AND ANTI-TUMOR AND ANTI-METASTATIC EFFECTS OF DUAL FUNCTIONAL CONJUGATE | PTMS, DNPEP, PAICS | PPARA 1204/4885KLK7 2545/4885KLK5 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.